nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Simvastatin—atherosclerosis	0.0701	0.0959	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0701	0.0959	CbGbCtD
Oxycodone—CYP3A7—Lovastatin—atherosclerosis	0.0686	0.0939	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0686	0.0939	CbGbCtD
Oxycodone—CYP3A5—Rosuvastatin—atherosclerosis	0.0566	0.0774	CbGbCtD
Oxycodone—CYP3A5—Simvastatin—atherosclerosis	0.0526	0.072	CbGbCtD
Oxycodone—CYP3A5—Pravastatin—atherosclerosis	0.0515	0.0704	CbGbCtD
Oxycodone—CYP3A5—Lovastatin—atherosclerosis	0.0515	0.0704	CbGbCtD
Oxycodone—CYP2D6—Niacin—atherosclerosis	0.0408	0.0558	CbGbCtD
Oxycodone—CYP2D6—Simvastatin—atherosclerosis	0.0323	0.0441	CbGbCtD
Oxycodone—CYP2D6—Lovastatin—atherosclerosis	0.0316	0.0432	CbGbCtD
Oxycodone—CYP2D6—Pravastatin—atherosclerosis	0.0316	0.0432	CbGbCtD
Oxycodone—CYP3A4—Ezetimibe—atherosclerosis	0.0221	0.0302	CbGbCtD
Oxycodone—CYP3A4—Rosuvastatin—atherosclerosis	0.0221	0.0302	CbGbCtD
Oxycodone—CYP3A4—Simvastatin—atherosclerosis	0.0205	0.0281	CbGbCtD
Oxycodone—CYP3A4—Pravastatin—atherosclerosis	0.0201	0.0275	CbGbCtD
Oxycodone—CYP3A4—Lovastatin—atherosclerosis	0.0201	0.0275	CbGbCtD
Oxycodone—Naloxone—TLR4—atherosclerosis	0.00239	0.711	CrCbGaD
Oxycodone—Naloxone—ESR1—atherosclerosis	0.00067	0.2	CrCbGaD
Oxycodone—Visual impairment—Pravastatin—atherosclerosis	0.000443	0.00219	CcSEcCtD
Oxycodone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000439	0.00217	CcSEcCtD
Oxycodone—Eye disorder—Niacin—atherosclerosis	0.000436	0.00216	CcSEcCtD
Oxycodone—Flatulence—Simvastatin—atherosclerosis	0.000436	0.00216	CcSEcCtD
Oxycodone—Tinnitus—Niacin—atherosclerosis	0.000435	0.00216	CcSEcCtD
Oxycodone—Dysgeusia—Simvastatin—atherosclerosis	0.000434	0.00215	CcSEcCtD
Oxycodone—Flushing—Niacin—atherosclerosis	0.000433	0.00215	CcSEcCtD
Oxycodone—Angioedema—Lovastatin—atherosclerosis	0.000433	0.00214	CcSEcCtD
Oxycodone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000431	0.00213	CcSEcCtD
Oxycodone—Anaemia—Ezetimibe—atherosclerosis	0.000429	0.00212	CcSEcCtD
Oxycodone—Tinnitus—Pravastatin—atherosclerosis	0.000429	0.00212	CcSEcCtD
Oxycodone—Malaise—Lovastatin—atherosclerosis	0.000427	0.00211	CcSEcCtD
Oxycodone—Flushing—Pravastatin—atherosclerosis	0.000427	0.00211	CcSEcCtD
Oxycodone—Cardiac disorder—Pravastatin—atherosclerosis	0.000427	0.00211	CcSEcCtD
Oxycodone—Muscle spasms—Simvastatin—atherosclerosis	0.000426	0.00211	CcSEcCtD
Oxycodone—Vertigo—Lovastatin—atherosclerosis	0.000425	0.0021	CcSEcCtD
Oxycodone—Angioedema—Ezetimibe—atherosclerosis	0.000424	0.0021	CcSEcCtD
Oxycodone—Angiopathy—Niacin—atherosclerosis	0.000424	0.0021	CcSEcCtD
Oxycodone—Leukopenia—Lovastatin—atherosclerosis	0.000424	0.0021	CcSEcCtD
Oxycodone—Chills—Niacin—atherosclerosis	0.000419	0.00207	CcSEcCtD
Oxycodone—Malaise—Ezetimibe—atherosclerosis	0.000419	0.00207	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000415	0.00206	CcSEcCtD
Oxycodone—Tremor—Simvastatin—atherosclerosis	0.000415	0.00205	CcSEcCtD
Oxycodone—Chills—Pravastatin—atherosclerosis	0.000413	0.00204	CcSEcCtD
Oxycodone—Insomnia—Rosuvastatin—atherosclerosis	0.000412	0.00204	CcSEcCtD
Oxycodone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000411	0.00203	CcSEcCtD
Oxycodone—Palpitations—Ezetimibe—atherosclerosis	0.00041	0.00203	CcSEcCtD
Oxycodone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000409	0.00203	CcSEcCtD
Oxycodone—Anaemia—Simvastatin—atherosclerosis	0.000409	0.00203	CcSEcCtD
Oxycodone—Malnutrition—Niacin—atherosclerosis	0.000407	0.00201	CcSEcCtD
Oxycodone—Cough—Ezetimibe—atherosclerosis	0.000405	0.00201	CcSEcCtD
Oxycodone—Angioedema—Simvastatin—atherosclerosis	0.000405	0.002	CcSEcCtD
Oxycodone—Arthralgia—Lovastatin—atherosclerosis	0.000403	0.00199	CcSEcCtD
Oxycodone—Chest pain—Lovastatin—atherosclerosis	0.000403	0.00199	CcSEcCtD
Oxycodone—Myalgia—Lovastatin—atherosclerosis	0.000403	0.00199	CcSEcCtD
Oxycodone—Anxiety—Lovastatin—atherosclerosis	0.000402	0.00199	CcSEcCtD
Oxycodone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000401	0.00199	CcSEcCtD
Oxycodone—Flatulence—Niacin—atherosclerosis	0.000401	0.00198	CcSEcCtD
Oxycodone—Malaise—Simvastatin—atherosclerosis	0.000399	0.00198	CcSEcCtD
Oxycodone—Tension—Niacin—atherosclerosis	0.000399	0.00197	CcSEcCtD
Oxycodone—Discomfort—Lovastatin—atherosclerosis	0.000398	0.00197	CcSEcCtD
Oxycodone—Vertigo—Simvastatin—atherosclerosis	0.000398	0.00197	CcSEcCtD
Oxycodone—Leukopenia—Simvastatin—atherosclerosis	0.000396	0.00196	CcSEcCtD
Oxycodone—Chest pain—Ezetimibe—atherosclerosis	0.000395	0.00196	CcSEcCtD
Oxycodone—Arthralgia—Ezetimibe—atherosclerosis	0.000395	0.00196	CcSEcCtD
Oxycodone—Myalgia—Ezetimibe—atherosclerosis	0.000395	0.00196	CcSEcCtD
Oxycodone—Nervousness—Niacin—atherosclerosis	0.000395	0.00195	CcSEcCtD
Oxycodone—Flatulence—Pravastatin—atherosclerosis	0.000394	0.00195	CcSEcCtD
Oxycodone—Dry mouth—Lovastatin—atherosclerosis	0.000394	0.00195	CcSEcCtD
Oxycodone—Tension—Pravastatin—atherosclerosis	0.000393	0.00194	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000393	0.00194	CcSEcCtD
Oxycodone—Dysgeusia—Pravastatin—atherosclerosis	0.000392	0.00194	CcSEcCtD
Oxycodone—Muscle spasms—Niacin—atherosclerosis	0.000391	0.00193	CcSEcCtD
Oxycodone—Discomfort—Ezetimibe—atherosclerosis	0.000391	0.00193	CcSEcCtD
Oxycodone—Pain—Rosuvastatin—atherosclerosis	0.00039	0.00193	CcSEcCtD
Oxycodone—Constipation—Rosuvastatin—atherosclerosis	0.00039	0.00193	CcSEcCtD
Oxycodone—Confusional state—Lovastatin—atherosclerosis	0.00039	0.00193	CcSEcCtD
Oxycodone—Nervousness—Pravastatin—atherosclerosis	0.000389	0.00192	CcSEcCtD
Oxycodone—Dry mouth—Ezetimibe—atherosclerosis	0.000387	0.00191	CcSEcCtD
Oxycodone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000386	0.00191	CcSEcCtD
Oxycodone—Muscle spasms—Pravastatin—atherosclerosis	0.000385	0.0019	CcSEcCtD
Oxycodone—Infection—Lovastatin—atherosclerosis	0.000384	0.0019	CcSEcCtD
Oxycodone—Confusional state—Ezetimibe—atherosclerosis	0.000382	0.00189	CcSEcCtD
Oxycodone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000379	0.00188	CcSEcCtD
Oxycodone—Myalgia—Simvastatin—atherosclerosis	0.000377	0.00187	CcSEcCtD
Oxycodone—Chest pain—Simvastatin—atherosclerosis	0.000377	0.00187	CcSEcCtD
Oxycodone—Arthralgia—Simvastatin—atherosclerosis	0.000377	0.00187	CcSEcCtD
Oxycodone—Infection—Ezetimibe—atherosclerosis	0.000376	0.00186	CcSEcCtD
Oxycodone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000376	0.00186	CcSEcCtD
Oxycodone—Anxiety—Simvastatin—atherosclerosis	0.000376	0.00186	CcSEcCtD
Oxycodone—Tremor—Pravastatin—atherosclerosis	0.000375	0.00186	CcSEcCtD
Oxycodone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000373	0.00184	CcSEcCtD
Oxycodone—Discomfort—Simvastatin—atherosclerosis	0.000372	0.00184	CcSEcCtD
Oxycodone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000372	0.00184	CcSEcCtD
Oxycodone—Angioedema—Niacin—atherosclerosis	0.000372	0.00184	CcSEcCtD
Oxycodone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000371	0.00184	CcSEcCtD
Oxycodone—Anaemia—Pravastatin—atherosclerosis	0.00037	0.00183	CcSEcCtD
Oxycodone—Anorexia—Lovastatin—atherosclerosis	0.000368	0.00182	CcSEcCtD
Oxycodone—Skin disorder—Ezetimibe—atherosclerosis	0.000368	0.00182	CcSEcCtD
Oxycodone—Angioedema—Pravastatin—atherosclerosis	0.000366	0.00181	CcSEcCtD
Oxycodone—Vertigo—Niacin—atherosclerosis	0.000365	0.00181	CcSEcCtD
Oxycodone—Syncope—Niacin—atherosclerosis	0.000365	0.0018	CcSEcCtD
Oxycodone—Confusional state—Simvastatin—atherosclerosis	0.000364	0.0018	CcSEcCtD
Oxycodone—Leukopenia—Niacin—atherosclerosis	0.000364	0.0018	CcSEcCtD
Oxycodone—Urticaria—Rosuvastatin—atherosclerosis	0.000362	0.00179	CcSEcCtD
Oxycodone—Oedema—Simvastatin—atherosclerosis	0.000361	0.00179	CcSEcCtD
Oxycodone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000361	0.00179	CcSEcCtD
Oxycodone—Malaise—Pravastatin—atherosclerosis	0.000361	0.00179	CcSEcCtD
Oxycodone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00036	0.00178	CcSEcCtD
Oxycodone—Vertigo—Pravastatin—atherosclerosis	0.00036	0.00178	CcSEcCtD
Oxycodone—Palpitations—Niacin—atherosclerosis	0.000359	0.00178	CcSEcCtD
Oxycodone—Infection—Simvastatin—atherosclerosis	0.000359	0.00178	CcSEcCtD
Oxycodone—Leukopenia—Pravastatin—atherosclerosis	0.000358	0.00177	CcSEcCtD
Oxycodone—Loss of consciousness—Niacin—atherosclerosis	0.000357	0.00177	CcSEcCtD
Oxycodone—Cough—Niacin—atherosclerosis	0.000355	0.00176	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000352	0.00174	CcSEcCtD
Oxycodone—Insomnia—Lovastatin—atherosclerosis	0.000349	0.00173	CcSEcCtD
Oxycodone—Cough—Pravastatin—atherosclerosis	0.000349	0.00173	CcSEcCtD
Oxycodone—Paraesthesia—Lovastatin—atherosclerosis	0.000347	0.00172	CcSEcCtD
Oxycodone—Myalgia—Niacin—atherosclerosis	0.000346	0.00171	CcSEcCtD
Oxycodone—Arthralgia—Niacin—atherosclerosis	0.000346	0.00171	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000345	0.00171	CcSEcCtD
Oxycodone—Anorexia—Simvastatin—atherosclerosis	0.000344	0.0017	CcSEcCtD
Oxycodone—Dyspnoea—Lovastatin—atherosclerosis	0.000344	0.0017	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000344	0.0017	CcSEcCtD
Oxycodone—Insomnia—Ezetimibe—atherosclerosis	0.000343	0.0017	CcSEcCtD
Oxycodone—Arthralgia—Pravastatin—atherosclerosis	0.000341	0.00169	CcSEcCtD
Oxycodone—Myalgia—Pravastatin—atherosclerosis	0.000341	0.00169	CcSEcCtD
Oxycodone—Chest pain—Pravastatin—atherosclerosis	0.000341	0.00169	CcSEcCtD
Oxycodone—Paraesthesia—Ezetimibe—atherosclerosis	0.00034	0.00168	CcSEcCtD
Oxycodone—Dyspepsia—Lovastatin—atherosclerosis	0.00034	0.00168	CcSEcCtD
Oxycodone—Anxiety—Pravastatin—atherosclerosis	0.00034	0.00168	CcSEcCtD
Oxycodone—Dry mouth—Niacin—atherosclerosis	0.000339	0.00168	CcSEcCtD
Oxycodone—Dyspnoea—Ezetimibe—atherosclerosis	0.000338	0.00167	CcSEcCtD
Oxycodone—Discomfort—Pravastatin—atherosclerosis	0.000337	0.00167	CcSEcCtD
Oxycodone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000336	0.00166	CcSEcCtD
Oxycodone—Decreased appetite—Lovastatin—atherosclerosis	0.000336	0.00166	CcSEcCtD
Oxycodone—Dyspepsia—Ezetimibe—atherosclerosis	0.000334	0.00165	CcSEcCtD
Oxycodone—Fatigue—Lovastatin—atherosclerosis	0.000333	0.00165	CcSEcCtD
Oxycodone—Oedema—Niacin—atherosclerosis	0.000332	0.00164	CcSEcCtD
Oxycodone—Anaphylactic shock—Niacin—atherosclerosis	0.000332	0.00164	CcSEcCtD
Oxycodone—Pain—Lovastatin—atherosclerosis	0.00033	0.00164	CcSEcCtD
Oxycodone—Constipation—Lovastatin—atherosclerosis	0.00033	0.00164	CcSEcCtD
Oxycodone—Confusional state—Pravastatin—atherosclerosis	0.000329	0.00163	CcSEcCtD
Oxycodone—Decreased appetite—Ezetimibe—atherosclerosis	0.000329	0.00163	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000329	0.00163	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000327	0.00162	CcSEcCtD
Oxycodone—Asthenia—Rosuvastatin—atherosclerosis	0.000327	0.00162	CcSEcCtD
Oxycodone—Insomnia—Simvastatin—atherosclerosis	0.000327	0.00162	CcSEcCtD
Oxycodone—Oedema—Pravastatin—atherosclerosis	0.000327	0.00162	CcSEcCtD
Oxycodone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000327	0.00162	CcSEcCtD
Oxycodone—Fatigue—Ezetimibe—atherosclerosis	0.000327	0.00162	CcSEcCtD
Oxycodone—Shock—Niacin—atherosclerosis	0.000326	0.00162	CcSEcCtD
Oxycodone—Infection—Pravastatin—atherosclerosis	0.000325	0.00161	CcSEcCtD
Oxycodone—Paraesthesia—Simvastatin—atherosclerosis	0.000325	0.00161	CcSEcCtD
Oxycodone—Constipation—Ezetimibe—atherosclerosis	0.000324	0.0016	CcSEcCtD
Oxycodone—Pain—Ezetimibe—atherosclerosis	0.000324	0.0016	CcSEcCtD
Oxycodone—Tachycardia—Niacin—atherosclerosis	0.000324	0.0016	CcSEcCtD
Oxycodone—Pruritus—Rosuvastatin—atherosclerosis	0.000323	0.0016	CcSEcCtD
Oxycodone—Skin disorder—Niacin—atherosclerosis	0.000322	0.0016	CcSEcCtD
Oxycodone—Dyspnoea—Simvastatin—atherosclerosis	0.000322	0.00159	CcSEcCtD
Oxycodone—Hyperhidrosis—Niacin—atherosclerosis	0.000321	0.00159	CcSEcCtD
Oxycodone—Feeling abnormal—Lovastatin—atherosclerosis	0.000318	0.00158	CcSEcCtD
Oxycodone—Dyspepsia—Simvastatin—atherosclerosis	0.000318	0.00157	CcSEcCtD
Oxycodone—Anorexia—Niacin—atherosclerosis	0.000316	0.00157	CcSEcCtD
Oxycodone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000316	0.00156	CcSEcCtD
Oxycodone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000316	0.00156	CcSEcCtD
Oxycodone—Decreased appetite—Simvastatin—atherosclerosis	0.000314	0.00155	CcSEcCtD
Oxycodone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000312	0.00155	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000312	0.00154	CcSEcCtD
Oxycodone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000312	0.00154	CcSEcCtD
Oxycodone—Fatigue—Simvastatin—atherosclerosis	0.000312	0.00154	CcSEcCtD
Oxycodone—Anorexia—Pravastatin—atherosclerosis	0.000311	0.00154	CcSEcCtD
Oxycodone—Hypotension—Niacin—atherosclerosis	0.00031	0.00153	CcSEcCtD
Oxycodone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00031	0.00153	CcSEcCtD
Oxycodone—Constipation—Simvastatin—atherosclerosis	0.000309	0.00153	CcSEcCtD
Oxycodone—Pain—Simvastatin—atherosclerosis	0.000309	0.00153	CcSEcCtD
Oxycodone—Urticaria—Lovastatin—atherosclerosis	0.000307	0.00152	CcSEcCtD
Oxycodone—Body temperature increased—Lovastatin—atherosclerosis	0.000305	0.00151	CcSEcCtD
Oxycodone—Abdominal pain—Lovastatin—atherosclerosis	0.000305	0.00151	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000302	0.0015	CcSEcCtD
Oxycodone—Dizziness—Rosuvastatin—atherosclerosis	0.000301	0.00149	CcSEcCtD
Oxycodone—Urticaria—Ezetimibe—atherosclerosis	0.000301	0.00149	CcSEcCtD
Oxycodone—Insomnia—Niacin—atherosclerosis	0.0003	0.00149	CcSEcCtD
Oxycodone—Abdominal pain—Ezetimibe—atherosclerosis	0.0003	0.00148	CcSEcCtD
Oxycodone—Body temperature increased—Ezetimibe—atherosclerosis	0.0003	0.00148	CcSEcCtD
Oxycodone—Naloxone—ALB—atherosclerosis	0.000298	0.0888	CrCbGaD
Oxycodone—Paraesthesia—Niacin—atherosclerosis	0.000298	0.00147	CcSEcCtD
Oxycodone—Feeling abnormal—Simvastatin—atherosclerosis	0.000298	0.00147	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000298	0.00147	CcSEcCtD
Oxycodone—Dyspnoea—Niacin—atherosclerosis	0.000296	0.00146	CcSEcCtD
Oxycodone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000296	0.00146	CcSEcCtD
Oxycodone—Insomnia—Pravastatin—atherosclerosis	0.000296	0.00146	CcSEcCtD
Oxycodone—Somnolence—Niacin—atherosclerosis	0.000295	0.00146	CcSEcCtD
Oxycodone—Paraesthesia—Pravastatin—atherosclerosis	0.000293	0.00145	CcSEcCtD
Oxycodone—Dyspepsia—Niacin—atherosclerosis	0.000292	0.00145	CcSEcCtD
Oxycodone—Dyspnoea—Pravastatin—atherosclerosis	0.000291	0.00144	CcSEcCtD
Oxycodone—Decreased appetite—Niacin—atherosclerosis	0.000288	0.00143	CcSEcCtD
Oxycodone—Dyspepsia—Pravastatin—atherosclerosis	0.000288	0.00142	CcSEcCtD
Oxycodone—Rash—Rosuvastatin—atherosclerosis	0.000287	0.00142	CcSEcCtD
Oxycodone—Dermatitis—Rosuvastatin—atherosclerosis	0.000287	0.00142	CcSEcCtD
Oxycodone—Urticaria—Simvastatin—atherosclerosis	0.000287	0.00142	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000286	0.00142	CcSEcCtD
Oxycodone—Abdominal pain—Simvastatin—atherosclerosis	0.000286	0.00141	CcSEcCtD
Oxycodone—Body temperature increased—Simvastatin—atherosclerosis	0.000286	0.00141	CcSEcCtD
Oxycodone—Headache—Rosuvastatin—atherosclerosis	0.000286	0.00141	CcSEcCtD
Oxycodone—Hypersensitivity—Lovastatin—atherosclerosis	0.000285	0.00141	CcSEcCtD
Oxycodone—Decreased appetite—Pravastatin—atherosclerosis	0.000284	0.00141	CcSEcCtD
Oxycodone—Pain—Niacin—atherosclerosis	0.000284	0.0014	CcSEcCtD
Oxycodone—Fatigue—Pravastatin—atherosclerosis	0.000282	0.00139	CcSEcCtD
Oxycodone—Constipation—Pravastatin—atherosclerosis	0.000279	0.00138	CcSEcCtD
Oxycodone—Pain—Pravastatin—atherosclerosis	0.000279	0.00138	CcSEcCtD
Oxycodone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000279	0.00138	CcSEcCtD
Oxycodone—Asthenia—Lovastatin—atherosclerosis	0.000277	0.00137	CcSEcCtD
Oxycodone—Pruritus—Lovastatin—atherosclerosis	0.000273	0.00135	CcSEcCtD
Oxycodone—Asthenia—Ezetimibe—atherosclerosis	0.000272	0.00135	CcSEcCtD
Oxycodone—Gastrointestinal pain—Niacin—atherosclerosis	0.000271	0.00134	CcSEcCtD
Oxycodone—Nausea—Rosuvastatin—atherosclerosis	0.000271	0.00134	CcSEcCtD
Oxycodone—Feeling abnormal—Pravastatin—atherosclerosis	0.000269	0.00133	CcSEcCtD
Oxycodone—Pruritus—Ezetimibe—atherosclerosis	0.000268	0.00133	CcSEcCtD
Oxycodone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000267	0.00132	CcSEcCtD
Oxycodone—Hypersensitivity—Simvastatin—atherosclerosis	0.000266	0.00132	CcSEcCtD
Oxycodone—Diarrhoea—Lovastatin—atherosclerosis	0.000264	0.00131	CcSEcCtD
Oxycodone—Urticaria—Niacin—atherosclerosis	0.000264	0.0013	CcSEcCtD
Oxycodone—Body temperature increased—Niacin—atherosclerosis	0.000262	0.0013	CcSEcCtD
Oxycodone—Abdominal pain—Niacin—atherosclerosis	0.000262	0.0013	CcSEcCtD
Oxycodone—Urticaria—Pravastatin—atherosclerosis	0.00026	0.00128	CcSEcCtD
Oxycodone—Asthenia—Simvastatin—atherosclerosis	0.000259	0.00128	CcSEcCtD
Oxycodone—Diarrhoea—Ezetimibe—atherosclerosis	0.000259	0.00128	CcSEcCtD
Oxycodone—Abdominal pain—Pravastatin—atherosclerosis	0.000258	0.00128	CcSEcCtD
Oxycodone—Body temperature increased—Pravastatin—atherosclerosis	0.000258	0.00128	CcSEcCtD
Oxycodone—Pruritus—Simvastatin—atherosclerosis	0.000256	0.00127	CcSEcCtD
Oxycodone—Dizziness—Lovastatin—atherosclerosis	0.000255	0.00126	CcSEcCtD
Oxycodone—Dizziness—Ezetimibe—atherosclerosis	0.000251	0.00124	CcSEcCtD
Oxycodone—Diarrhoea—Simvastatin—atherosclerosis	0.000247	0.00122	CcSEcCtD
Oxycodone—Vomiting—Lovastatin—atherosclerosis	0.000246	0.00122	CcSEcCtD
Oxycodone—Hypersensitivity—Niacin—atherosclerosis	0.000244	0.00121	CcSEcCtD
Oxycodone—Rash—Lovastatin—atherosclerosis	0.000244	0.00121	CcSEcCtD
Oxycodone—Dermatitis—Lovastatin—atherosclerosis	0.000243	0.0012	CcSEcCtD
Oxycodone—Headache—Lovastatin—atherosclerosis	0.000242	0.0012	CcSEcCtD
Oxycodone—Vomiting—Ezetimibe—atherosclerosis	0.000241	0.00119	CcSEcCtD
Oxycodone—Hypersensitivity—Pravastatin—atherosclerosis	0.000241	0.00119	CcSEcCtD
Oxycodone—Dizziness—Simvastatin—atherosclerosis	0.000239	0.00118	CcSEcCtD
Oxycodone—Rash—Ezetimibe—atherosclerosis	0.000239	0.00118	CcSEcCtD
Oxycodone—Dermatitis—Ezetimibe—atherosclerosis	0.000239	0.00118	CcSEcCtD
Oxycodone—Asthenia—Niacin—atherosclerosis	0.000238	0.00118	CcSEcCtD
Oxycodone—Headache—Ezetimibe—atherosclerosis	0.000237	0.00117	CcSEcCtD
Oxycodone—Pruritus—Niacin—atherosclerosis	0.000235	0.00116	CcSEcCtD
Oxycodone—Asthenia—Pravastatin—atherosclerosis	0.000234	0.00116	CcSEcCtD
Oxycodone—Pruritus—Pravastatin—atherosclerosis	0.000231	0.00114	CcSEcCtD
Oxycodone—Vomiting—Simvastatin—atherosclerosis	0.00023	0.00114	CcSEcCtD
Oxycodone—Nausea—Lovastatin—atherosclerosis	0.000229	0.00114	CcSEcCtD
Oxycodone—Rash—Simvastatin—atherosclerosis	0.000228	0.00113	CcSEcCtD
Oxycodone—Dermatitis—Simvastatin—atherosclerosis	0.000228	0.00113	CcSEcCtD
Oxycodone—Diarrhoea—Niacin—atherosclerosis	0.000227	0.00112	CcSEcCtD
Oxycodone—Headache—Simvastatin—atherosclerosis	0.000226	0.00112	CcSEcCtD
Oxycodone—Nausea—Ezetimibe—atherosclerosis	0.000225	0.00111	CcSEcCtD
Oxycodone—Diarrhoea—Pravastatin—atherosclerosis	0.000224	0.00111	CcSEcCtD
Oxycodone—Dizziness—Niacin—atherosclerosis	0.000219	0.00109	CcSEcCtD
Oxycodone—Dizziness—Pravastatin—atherosclerosis	0.000216	0.00107	CcSEcCtD
Oxycodone—Nausea—Simvastatin—atherosclerosis	0.000215	0.00106	CcSEcCtD
Oxycodone—Vomiting—Niacin—atherosclerosis	0.000211	0.00104	CcSEcCtD
Oxycodone—Rash—Niacin—atherosclerosis	0.000209	0.00104	CcSEcCtD
Oxycodone—Dermatitis—Niacin—atherosclerosis	0.000209	0.00103	CcSEcCtD
Oxycodone—Headache—Niacin—atherosclerosis	0.000208	0.00103	CcSEcCtD
Oxycodone—Vomiting—Pravastatin—atherosclerosis	0.000208	0.00103	CcSEcCtD
Oxycodone—Rash—Pravastatin—atherosclerosis	0.000206	0.00102	CcSEcCtD
Oxycodone—Dermatitis—Pravastatin—atherosclerosis	0.000206	0.00102	CcSEcCtD
Oxycodone—Headache—Pravastatin—atherosclerosis	0.000205	0.00101	CcSEcCtD
Oxycodone—Nausea—Niacin—atherosclerosis	0.000197	0.000975	CcSEcCtD
Oxycodone—Nausea—Pravastatin—atherosclerosis	0.000194	0.00096	CcSEcCtD
Oxycodone—CYP2D6—Metabolism—FABP4—atherosclerosis	2.06e-05	0.000323	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LCAT—atherosclerosis	2.06e-05	0.000323	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LPL—atherosclerosis	2.06e-05	0.000322	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—F2—atherosclerosis	2.04e-05	0.00032	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA4—atherosclerosis	2.02e-05	0.000317	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	2.02e-05	0.000317	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	2e-05	0.000313	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ABCA1—atherosclerosis	2e-05	0.000313	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.99e-05	0.000312	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP3—atherosclerosis	1.95e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	1.95e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SPP1—atherosclerosis	1.95e-05	0.000305	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF2—atherosclerosis	1.95e-05	0.000305	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	1.94e-05	0.000304	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOB—atherosclerosis	1.89e-05	0.000296	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	1.87e-05	0.000294	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.87e-05	0.000293	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KNG1—atherosclerosis	1.86e-05	0.000292	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EDN1—atherosclerosis	1.86e-05	0.000291	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LIPC—atherosclerosis	1.86e-05	0.000291	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	1.85e-05	0.00029	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOC3—atherosclerosis	1.85e-05	0.000289	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL5—atherosclerosis	1.84e-05	0.000289	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.84e-05	0.000288	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LDLR—atherosclerosis	1.83e-05	0.000287	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	1.82e-05	0.000285	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.81e-05	0.000284	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.81e-05	0.000284	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PLG—atherosclerosis	1.81e-05	0.000283	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LPL—atherosclerosis	1.8e-05	0.000283	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	1.8e-05	0.000282	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CETP—atherosclerosis	1.79e-05	0.000281	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AGT—atherosclerosis	1.76e-05	0.000276	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	1.75e-05	0.000275	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.74e-05	0.000273	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA2—atherosclerosis	1.74e-05	0.000273	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.74e-05	0.000273	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.74e-05	0.000273	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APOE—atherosclerosis	1.72e-05	0.00027	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LEP—atherosclerosis	1.72e-05	0.00027	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.72e-05	0.00027	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.72e-05	0.000269	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.71e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	1.71e-05	0.000268	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CAV1—atherosclerosis	1.71e-05	0.000268	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SPP1—atherosclerosis	1.71e-05	0.000268	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APOA1—atherosclerosis	1.7e-05	0.000267	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	1.7e-05	0.000267	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPA—atherosclerosis	1.66e-05	0.000261	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP3—atherosclerosis	1.65e-05	0.000259	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ESR1—atherosclerosis	1.65e-05	0.000258	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF2—atherosclerosis	1.64e-05	0.000258	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOB—atherosclerosis	1.64e-05	0.000257	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—F2—atherosclerosis	1.63e-05	0.000255	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.62e-05	0.000254	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BGN—atherosclerosis	1.61e-05	0.000252	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.6e-05	0.00025	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOB—atherosclerosis	1.6e-05	0.00025	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA5—atherosclerosis	1.59e-05	0.00025	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.58e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	1.58e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EDN1—atherosclerosis	1.57e-05	0.000246	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—LPL—atherosclerosis	1.57e-05	0.000246	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL5—atherosclerosis	1.56e-05	0.000244	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	1.56e-05	0.000244	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AGT—atherosclerosis	1.54e-05	0.000242	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.53e-05	0.00024	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPX1—atherosclerosis	1.53e-05	0.00024	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LPL—atherosclerosis	1.52e-05	0.000239	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOE—atherosclerosis	1.51e-05	0.000237	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LEP—atherosclerosis	1.51e-05	0.000237	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CAV1—atherosclerosis	1.5e-05	0.000235	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOA1—atherosclerosis	1.49e-05	0.000234	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	1.49e-05	0.000234	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CD36—atherosclerosis	1.49e-05	0.000233	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	1.48e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.48e-05	0.000232	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—INS—atherosclerosis	1.47e-05	0.000231	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL2—atherosclerosis	1.45e-05	0.000227	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.44e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.44e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—atherosclerosis	1.44e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.44e-05	0.000225	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.43e-05	0.000225	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—F2—atherosclerosis	1.43e-05	0.000223	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—atherosclerosis	1.42e-05	0.000223	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.41e-05	0.000221	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARA—atherosclerosis	1.38e-05	0.000217	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	1.36e-05	0.000214	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.35e-05	0.000212	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.35e-05	0.000211	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.35e-05	0.000211	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AGT—atherosclerosis	1.34e-05	0.00021	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.34e-05	0.000209	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.33e-05	0.000208	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.32e-05	0.000207	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LIPC—atherosclerosis	1.32e-05	0.000207	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—atherosclerosis	1.31e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOC3—atherosclerosis	1.31e-05	0.000206	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	1.31e-05	0.000205	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LDLR—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CAV1—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOA1—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOS3—atherosclerosis	1.29e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—INS—atherosclerosis	1.29e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.28e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.28e-05	0.0002	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CETP—atherosclerosis	1.27e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—atherosclerosis	1.27e-05	0.000199	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.27e-05	0.000198	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.26e-05	0.000198	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—atherosclerosis	1.25e-05	0.000196	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.24e-05	0.000194	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.22e-05	0.000191	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.22e-05	0.000191	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—F2—atherosclerosis	1.2e-05	0.000189	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.2e-05	0.000188	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOB—atherosclerosis	1.19e-05	0.000186	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	1.19e-05	0.000186	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.19e-05	0.000186	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.15e-05	0.000181	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.15e-05	0.000181	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.15e-05	0.000181	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	1.15e-05	0.00018	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LPL—atherosclerosis	1.13e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—atherosclerosis	1.13e-05	0.000178	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.13e-05	0.000176	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—INS—atherosclerosis	1.12e-05	0.000176	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.11e-05	0.000173	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX1—atherosclerosis	1.11e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.1e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—INS—atherosclerosis	1.09e-05	0.000171	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—atherosclerosis	1.09e-05	0.000171	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPA—atherosclerosis	1.09e-05	0.00017	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CD36—atherosclerosis	1.08e-05	0.000169	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—atherosclerosis	1.07e-05	0.000168	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—atherosclerosis	1.06e-05	0.000165	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BGN—atherosclerosis	1.05e-05	0.000165	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA5—atherosclerosis	1.04e-05	0.000163	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—atherosclerosis	1.04e-05	0.000162	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—atherosclerosis	1.03e-05	0.000161	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.03e-05	0.000161	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	0.000161	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.02e-05	0.00016	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	1.01e-05	0.000158	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	1e-05	0.000158	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	1e-05	0.000157	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1e-05	0.000157	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	1e-05	0.000157	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARA—atherosclerosis	1e-05	0.000157	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—atherosclerosis	9.84e-06	0.000154	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	9.7e-06	0.000152	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AGT—atherosclerosis	9.69e-06	0.000152	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.69e-06	0.000152	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—atherosclerosis	9.57e-06	0.00015	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—atherosclerosis	9.55e-06	0.00015	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—atherosclerosis	9.5e-06	0.000149	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAV1—atherosclerosis	9.41e-06	0.000148	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOA1—atherosclerosis	9.39e-06	0.000147	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	9.3e-06	0.000146	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—atherosclerosis	9.21e-06	0.000144	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—atherosclerosis	9.09e-06	0.000142	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—atherosclerosis	9e-06	0.000141	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	8.99e-06	0.000141	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	8.84e-06	0.000139	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	8.81e-06	0.000138	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.81e-06	0.000138	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	8.8e-06	0.000138	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.69e-06	0.000136	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LIPC—atherosclerosis	8.63e-06	0.000135	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOC3—atherosclerosis	8.58e-06	0.000134	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8.57e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	8.54e-06	0.000134	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LDLR—atherosclerosis	8.53e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	8.49e-06	0.000133	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOB—atherosclerosis	8.44e-06	0.000132	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CETP—atherosclerosis	8.33e-06	0.000131	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—atherosclerosis	8.27e-06	0.00013	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—atherosclerosis	8.21e-06	0.000129	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	8.2e-06	0.000129	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	8.16e-06	0.000128	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—INS—atherosclerosis	8.11e-06	0.000127	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—atherosclerosis	8.08e-06	0.000127	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—atherosclerosis	8.07e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPL—atherosclerosis	8.06e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.98e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX1—atherosclerosis	7.86e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	7.72e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—atherosclerosis	7.68e-06	0.00012	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CD36—atherosclerosis	7.66e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	7.6e-06	0.000119	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.53e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	7.49e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	7.47e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	7.45e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—atherosclerosis	7.44e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.25e-06	0.000114	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARA—atherosclerosis	7.12e-06	0.000112	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—atherosclerosis	7.12e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	6.9e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AGT—atherosclerosis	6.89e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—atherosclerosis	6.83e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—atherosclerosis	6.75e-06	0.000106	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.71e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAV1—atherosclerosis	6.69e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA1—atherosclerosis	6.68e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	6.52e-06	0.000102	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.51e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—atherosclerosis	6.43e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	6.33e-06	9.92e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.1e-06	9.55e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—atherosclerosis	5.94e-06	9.31e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—atherosclerosis	5.88e-06	9.22e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—INS—atherosclerosis	5.77e-06	9.04e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.76e-06	9.03e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—atherosclerosis	5.64e-06	8.84e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOB—atherosclerosis	5.52e-06	8.65e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.37e-06	8.41e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—atherosclerosis	5.29e-06	8.29e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPL—atherosclerosis	5.27e-06	8.26e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—atherosclerosis	5.21e-06	8.16e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX1—atherosclerosis	5.14e-06	8.06e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—atherosclerosis	5.06e-06	7.93e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CD36—atherosclerosis	5.01e-06	7.85e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—atherosclerosis	4.77e-06	7.47e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.74e-06	7.43e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARA—atherosclerosis	4.65e-06	7.29e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.63e-06	7.25e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—atherosclerosis	4.53e-06	7.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AGT—atherosclerosis	4.51e-06	7.06e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—atherosclerosis	4.42e-06	6.92e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—atherosclerosis	4.4e-06	6.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAV1—atherosclerosis	4.38e-06	6.86e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA1—atherosclerosis	4.37e-06	6.84e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.99e-06	6.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.85e-06	6.03e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—INS—atherosclerosis	3.77e-06	5.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—atherosclerosis	3.46e-06	5.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—atherosclerosis	3.31e-06	5.19e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—atherosclerosis	3.27e-06	5.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.03e-06	4.74e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—atherosclerosis	2.33e-06	3.65e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.52e-06	2.38e-05	CbGpPWpGaD
